The Director of North America Regulatory Strategy (NA GRA) will be primarily responsible for the development of US regulatory strategy to advance Rare Disease portfolio of development pipeline candidates and lifecycle management of marketed products. Reporting to the Associate Vice President of North America Regulatory Affairs, this individual will work within the Global Regulatory Team to provide strategic input and ensure operational execution of US submission activities for the Rare Disease portfolio. The individual will be responsible to interface directly with the US FDA as the primary contact for the company for assigned programs.
Specific responsibilities include:
- Responsible to proactively develop innovative, robust US regulatory strategies and ensure their efficient and effective execution for pipeline and lifecycle assets in clinical development for rare disease indications which adhere to US regulatory and company guidelines.
- Represent the NA GRA perspective as a member of project specific cross-functional global regulatory team (GRT) and be accountable to develop and maintain US aspects of regulatory strategy documents.
- Lead the strategic development of briefing materials and prepare teams for US FDA meetings.
- Participate in the development of and assess the appropriateness of submission documentation to support successful INDs/NDAs/BLAs.
- Represent company at US FDA for assigned projects.
- Work with the NA labeling strategist and the Global Regulatory Team to develop US prescribing information.
- Work with and participate on multi-disciplinary matrixed project teams to successfully meet project deliverables while adhering to regulatory requirements for programs and products.
- Consult with senior management to develop and communicate regulatory strategies and advice for products and programs.
- Participate in the development and monitoring of the US regulatory environment and updating of standards and processes related to drug and biologics US regulations.
- Ensure compliance with all regulatory and internal policies
Minimum Requirements:
- At least 10 years’ regulatory experience in pharmaceutical drug development.
- Solid working knowledge of drug development process and US regulatory requirements.
- Demonstrated experience developing and implementing regulatory strategies for US INDs, BLA, and/or NDAs
- Experience with rare disease drug development.
- Demonstrated experience successfully operating in a global environment.
- Advanced scientific degree preferred. B.A./B.S. or higher degree (s) in the sciences, or health-related field minimum, with 8 years regulatory experience.
Knowledge, Skills and Other Experience
- Solid knowledge and understanding of complex medical and scientific subject matter as well as evolving US regulatory policy and guidance
- Direct interaction/negotiation experience with US FDA.
- Strong strategic skills including the ability to make complex decisions and willingness to defend difficult positions.
- Excellent operational skills including planning, organizing and ability to motivate and lead others.
- Demonstrates excellent oral communication and writing skills
- Understanding of the U.S. pharmaceutical marketplace and familiarity with medical terminology. Ability to understand issues, problems, and opportunities by comparing data from different sources to draw conclusions and then can choose a course of action or develop the appropriate solution.
- Unquestionable ethics, professional integrity, and personal values consistent with the company values
COMPENSATION
Bonus Eligible - Yes, 18%
Location:
Bridgewater, NJ or Cambridge, MA.
Company Description:Our Client is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, their unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in their own laboratories. Their medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases and rare diseases.